Roughly 2.3 million women are diagnosed with breast cancer worldwide each year, making it the most common cancer in women globally. In the United States alone, an estimated 321,910 new cases of female breast cancer are projected for 2026, along with about 59,080 cases of ductal carcinoma in situ, an early, non-invasive form of the disease.
Global and US Numbers at a Glance
The 2.3 million global figure comes from 2022 data compiled by the World Health Organization, and the number has been climbing steadily for decades as populations age and screening expands. That same year, breast cancer caused an estimated 670,000 deaths worldwide.
Within the US, breast cancer accounts for roughly one in six of all new cancer diagnoses projected for 2025 and 2026. The 321,910 invasive cases expected in 2026 don’t include the additional 59,080 in situ cases, which are confined to the milk ducts and haven’t spread into surrounding tissue. When you combine both, nearly 380,000 American women will receive some form of breast cancer diagnosis this year.
Who Gets Diagnosed Most Often
Age is the single biggest factor. The median age at diagnosis is 62, and the vast majority of cases occur in women over 50. Women under 40 account for a small fraction of diagnoses, though breast cancer in younger women tends to be more aggressive when it does occur.
Race and ethnicity also shape the picture. White women have the highest overall incidence rate at roughly 187 per 100,000, followed by Black women at about 174 per 100,000. Asian and Pacific Islander women have seen the fastest-rising rates, increasing an average of 1.4% per year since 2005. American Indian and Alaska Native women experienced a similar upward trend of 1.4% annually through 2016 before rates leveled off. Hispanic women have the lowest incidence among major racial groups, at around 134 per 100,000.
These gaps matter beyond just diagnosis numbers. Black women, despite having a slightly lower incidence rate than white women, face significantly higher mortality from breast cancer, a disparity driven by later-stage diagnoses, differences in tumor biology, and unequal access to timely treatment.
Breast Cancer in Men
About 1 out of every 100 breast cancers diagnosed in the United States is found in a man. That translates to roughly 2,800 to 3,200 male cases per year. Men have breast tissue too, and though the risk is low, male breast cancer is often caught later because most men aren’t aware it’s possible.
Survival Rates by Stage
How early breast cancer is caught changes the outcome dramatically. The most recent five-year relative survival data from the National Cancer Institute, covering 2013 through 2019, breaks down like this:
- Localized (cancer hasn’t spread beyond the breast): 99.3% five-year survival
- Regional (spread to nearby lymph nodes): 86.3%
- Distant (metastatic, spread to other organs): 31%
The gap between localized and distant disease is enormous. Most breast cancers in the US are still caught at the localized stage, which is a major reason the overall survival picture has improved so much over the past few decades. Still, even in countries with well-established screening programs, less than half of all breast cancers are detected through routine mammography. Many are found by patients themselves or through diagnostic imaging done for other reasons.
How Many People Die From Breast Cancer
Globally, breast cancer kills roughly 670,000 people per year. In the United States, an estimated 42,140 women are projected to die from the disease in 2026. That makes breast cancer the second leading cause of cancer death among American women, behind lung cancer.
The death toll has been dropping steadily since the early 1990s, driven by earlier detection and better treatment options. But the decline hasn’t been evenly distributed. Mortality reductions have been slower among Black women and in communities with limited access to screening and follow-up care, which is why the racial gap in breast cancer deaths has actually widened over time even as overall numbers improve.
Why the Numbers Keep Rising
The increasing number of breast cancer diagnoses worldwide reflects several overlapping trends. Populations are aging, and cancer risk rises with age. More countries are adopting screening programs, which catch cancers that previously would have gone undetected until later stages. Lifestyle shifts, including rising obesity rates, later age at first pregnancy, and lower rates of breastfeeding, all contribute to higher risk at the population level. Alcohol consumption, even at moderate levels, is an established risk factor as well.
In the US specifically, the slight upward trend in incidence since the mid-2000s is partly explained by increased use of genetic testing and improved imaging, which identify cancers that older technology would have missed. Whether that represents true overdiagnosis or genuinely useful early detection is still debated among cancer researchers, but for the individual patient, a diagnosis at the localized stage carries a near-perfect five-year survival rate.